HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+15.22%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$280M
AUM Growth
+$280M
(+1.8%)
Cap. Flow
-$16.9M
Cap. Flow
% of AUM
-6.04%
Top 10 Holdings %
Top 10 Hldgs %
28.7%
Holding
166
New
40
Increased
28
Reduced
35
Closed
35
Top Buys
| 1 |
Apogee Therapeutics
APGE
|
$7.93M |
| 2 |
ANSS
Ansys
ANSS
|
$4.44M |
| 3 |
JNPR
Juniper Networks
JNPR
|
$4.25M |
| 4 |
VanEck Gold Miners ETF
GDX
|
$2.78M |
| 5 |
Keros Therapeutics
KROS
|
$2.6M |
Top Sells
| 1 |
Spyre Therapeutics
SYRE
|
$16.1M |
| 2 |
Immunovant
IMVT
|
$5.11M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$4.29M |
| 4 |
SPLK
Splunk Inc
SPLK
|
$4.2M |
| 5 |
SOVO
Sovos Brands, Inc. Common Stock
SOVO
|
$4.07M |
Sector Composition
| 1 | Healthcare | 44.78% |
| 2 | Technology | 11.84% |
| 3 | Consumer Discretionary | 7.8% |
| 4 | Industrials | 6.17% |
| 5 | Financials | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
MoonLake Immunotherapeutics
MLTX
$3.78B
| $3M | 1.07% |
59,769
| – | – |
|
27
RTX Corp
RTX
$212B
| $2.96M | 1.05% |
30,300
+10,100
| +50% | +$985K |
|
28
Xoma
XOMA
$421M
| $2.86M | 1.02% |
118,899
| – | – |
|
29
Olema Pharmaceuticals
OLMA
$432M
| $2.81M | 1% |
247,880
| – | – |
|
|
30
VanEck Gold Miners ETF
GDX
$19.6B
| $2.78M | 0.99% |
+87,800
| New | +$2.78M |
|
31
Booking.com
BKNG
$181B
| $2.75M | 0.98% |
757
+100
| +15% | +$363K |
|
32
argenx
ARGX
$44.2B
| $2.66M | 0.95% |
6,745
+5,678
| +532% | +$2.24M |
|
|
33
Keros Therapeutics
KROS
$640M
| $2.6M | 0.93% |
+39,208
| New | +$2.6M |
|
|
SWTX
34
DELISTED
SpringWorks Therapeutics
SWTX
| $2.51M | 0.89% |
+50,987
| New | +$2.51M |
|
35
Visa
V
$681B
| $2.49M | 0.89% |
8,927
-3,400
| -28% | -$949K |
|
36
Orthofix Medical
OFIX
$583M
| $2.44M | 0.87% |
+167,900
| New | +$2.44M |
|
37
WESCO International
WCC
$10.6B
| $2.43M | 0.87% |
14,197
+2,100
| +17% | +$360K |
|
38
Laureate Education
LAUR
$4.12B
| $2.38M | 0.85% |
163,507
+21,000
| +15% | +$306K |
|
39
Maplebear
CART
$11.7B
| $2.33M | 0.83% |
+62,400
| New | +$2.33M |
|
40
MRC Global
MRC
$1.25B
| $2.27M | 0.81% |
180,400
+28,600
| +19% | +$360K |
|
41
Immunocore
IMCR
$1.78B
| $2.26M | 0.81% |
34,762
-6,865
| -16% | -$446K |
|
42
Roivant Sciences
ROIV
$8.6B
| $2.24M | 0.8% |
212,118
+157,188
| +286% | +$1.66M |
|
43
Enliven Therapeutics
ELVN
$1.24B
| $2.23M | 0.8% |
126,854
-10,387
| -8% | -$183K |
|
44
Meta Platforms (Facebook)
META
$1.85T
| $2.18M | 0.78% |
4,490
-2,400
| -35% | -$1.17M |
|
45
Arvinas
ARVN
$580M
| $2.11M | 0.75% |
+51,122
| New | +$2.11M |
|
46
Legend Biotech
LEGN
$6.64B
| $2.04M | 0.73% |
36,385
-7,920
| -18% | -$444K |
|
47
Fiserv
FI
$74.3B
| $2.02M | 0.72% |
12,653
-2,300
| -15% | -$368K |
|
48
Dynavax Technologies
DVAX
$1.19B
| $1.94M | 0.69% |
156,161
| – | – |
|
49
Intuit
INTU
$187B
| $1.93M | 0.69% |
2,963
-200
| -6% | -$130K |
|
50
Lithia Motors
LAD
$8.51B
| $1.93M | 0.69% |
6,401
+1,200
| +23% | +$361K |
|